Fatal outcome in a liver transplant recipient treated with activated protein C
Jana Hudcova, Roman Schumann – 24 November 2009
Jana Hudcova, Roman Schumann – 24 November 2009
Pratima Sharma, Douglas E. Schaubel, Mary K. Guidinger, Robert M. Merion – 24 November 2009 – More candidates with creatinine levels ≥ 2 mg/dL have undergone liver transplantation (LT) since the implementation of Model for End‐Stage Liver Disease (MELD)–based allocation. These candidates have higher posttransplant mortality. This study examined the effect of serum creatinine on survival benefit among candidates undergoing LT. Scientific Registry of Transplant Recipients data were analyzed for adult LT candidates listed between September 2001 and December 2006 (n = 38,899).
Tsan‐Shiun Lin, Allan M. Concejero, Chao‐Long Chen, Yuan‐Cheng Chiang, Chih‐Chi Wang, Shih‐Ho Wang, Yueh‐Wei Liu, Chin‐Hsiang Yang, Chee‐Chien Yong, Bruno Jawan, Yu‐Fan Cheng – 24 November 2009 – Biliary reconstruction using a microsurgical technique in living donor liver transplantation was routinely performed on 88 grafts primarily transplanted into 85 patients. All procedures were performed under a microscope by a single microsurgeon. Except for biliary atresia and Alagille syndrome, duct‐to‐duct reconstruction was performed. Stents were not used.
Chuan Yin, Wei‐Fen Xie – 20 November 2009
Manuel Mendizabal, Terina Chen, K. Rajender Reddy – 20 November 2009
Yusuf Yilmaz, Oya Yonal, Nese Imeryuz – 20 November 2009
Michael Charlton – 20 November 2009
Jordi Bruix, Keith Lindor – 20 November 2009
Anna Alisi, Massimo Pinzani, Valerio Nobili – 20 November 2009
Alexandra Sharland, Mark D. Gorrell – 20 November 2009